Article
The year 2004 has been marked by important developments in IOLs.
Ocular pain in Tibetan Plateau residents: Key findings on dry eye disease during COVID-19
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept
Understanding cerebral/cortical visual impairment: New insights and advances in diagnosis